These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1310891)

  • 41. Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
    Gridelli C; Contegiacomo A; Lauria R; Gentile M; Airoma G; De Placido S; Perrone F; Ferrante G; Bianco AR
    Tumori; 1991 Dec; 77(6):506-10. PubMed ID: 1666468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapidly expanding exophthalmos: an unusual presentation of small cell lung cancer.
    Spaide RF; Granger E; Hammer BD; Negron FJ; Paglen PG
    Br J Ophthalmol; 1989 Jun; 73(6):461-2. PubMed ID: 2546578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Polychemotherapy and radiotherapy for small cell cancer of the lung].
    Linchenko IF; Danil'ian VM
    Vopr Onkol; 1983; 29(9):106-14. PubMed ID: 6314659
    [No Abstract]   [Full Text] [Related]  

  • 44. Protocol cost analysis.
    Brown JK
    Prog Clin Biol Res; 1986; 216():199-204. PubMed ID: 3014557
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical trials referral resource. Small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Jan; 4(1):43-56. PubMed ID: 2168198
    [No Abstract]   [Full Text] [Related]  

  • 46. [Recent progress in the treatment of ED small cell lung cancer].
    Nokihara H; Ohe Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():480-4. PubMed ID: 12101718
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of polychemotherapy of small cell lung carcinoma].
    Mehić B; Zutić H; Dizdarević Z; Lovre V; Pećanac M
    Med Arh; 1995; 49(3-4 Suppl 1):81-3. PubMed ID: 9623075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
    Petrova IV; Stepovaia EA; Sokolova IB; Gol'dberg VE; Chasovskikh NIu; Koreshkova KG; Bazhenova NG; Kolosova MV; Baskakov MB; Novitskiĭ VV; Medvedev MA
    Biull Eksp Biol Med; 1997 Aug; 124(8):195-8. PubMed ID: 9410209
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical trials of cyclophosphamide, etoposide, and vincristine in the treatment of small-cell lung cancer.
    Comis RL
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):40-4. PubMed ID: 3020699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chemotherapy treatment for anti-Hu paraneoplastic syndrome without active malignancy].
    Gaillard N; Charif M; Carlander B; Pujol JL; Touchon J
    Rev Neurol (Paris); 2006 Sep; 162(8-9):862-5. PubMed ID: 17028549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
    Ferroir JP; Milleron B; Ropert A; Billy C; Nahum L; Tcherakian S; Carette MF
    Rev Pneumol Clin; 1999 Jun; 55(3):168-70. PubMed ID: 10486838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of surgical treatment in the combination therapy of small cell lung cancer (SCLC)].
    Yamaguchi Y; Momiki S; Kimura H; Ogawa T; Baba M
    Kyobu Geka; 1988 Mar; 41(3):184-9. PubMed ID: 2838669
    [No Abstract]   [Full Text] [Related]  

  • 53. Small cell lung cancer with paraneoplastic nephrotic syndrome.
    Boon ES; Vrij AA; Nieuwhof C; van Noord JA; Zeppenfeldt E
    Eur Respir J; 1994 Jun; 7(6):1192-3. PubMed ID: 7925893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small-cell lung cancer, high growth rate, high response rate to chemotherapy: ideal for high-dose chemotherapy?
    Galani E; Ellis PA; Harper PG
    J Clin Oncol; 2002 Oct; 20(19):3941-3. PubMed ID: 12351589
    [No Abstract]   [Full Text] [Related]  

  • 55. Vindesine and etoposide chemotherapy in the management of patients with small cell lung cancer and poor prognosis.
    Iredale JP; Hooi LM; Kerr KM; Sudlow MF; Wathen CG
    Respiration; 1991; 58(2):77-80. PubMed ID: 1650490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
    Klastersky J; Sculier JP; Dumont JP; Becquart D; Vandermoten G; Rocmans P; Michel J; Longeval E; Dalesio O
    Cancer; 1985 Jul; 56(1):71-5. PubMed ID: 2988738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Giaccone G; Dalesio O; McVie GJ; Kirkpatrick A; Postmus PE; Burghouts JT; Bakker W; Koolen MG; Vendrik CP; Roozendaal KJ
    J Clin Oncol; 1993 Jul; 11(7):1230-40. PubMed ID: 8391065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
    Tho LM; Ferry DR
    Postgrad Med J; 2005 Nov; 81(961):e17. PubMed ID: 16272226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination chemotherapy for small cell lung cancer.
    Sufarlan AW; Zainudin BM
    Med J Malaysia; 1993 Jun; 48(2):166-70. PubMed ID: 8394502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.